I am an Executive Director and Head of the Novartis Emeryville Protein Interactomics Center (EPICenter).
EPICenter is a structure-based center of excellence to identify transformative medicines based on novel molecular mechanisms with a focus on complex and difficult to drug targets.
I have 30 years working in drug discovery and my goal is to help patients with new drugs for unmet medical needs.